Futura Medical plc
FAMDF
$0.15
$0.017.14%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 361.85% | 376.66% | 405.02% | 601.74% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 361.85% | 376.66% | 405.02% | 601.74% | -- |
| Cost of Revenue | 228.61% | 236.20% | 249.66% | 428.09% | -- |
| Gross Profit | 461.33% | 487.44% | 540.74% | 753.49% | -- |
| SG&A Expenses | 4.55% | 44.28% | 117.81% | 134.24% | 150.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.22% | 46.60% | 71.41% | 62.87% | 48.78% |
| Operating Income | 118.23% | 77.40% | 26.66% | 9.42% | -3.08% |
| Income Before Tax | 119.11% | 78.59% | 28.75% | 10.98% | -2.02% |
| Income Tax Expenses | 100.15% | 74.14% | 61.99% | 61.64% | 62.26% |
| Earnings from Continuing Operations | 120.21% | 79.06% | 23.09% | 2.23% | -13.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 120.21% | 79.06% | 23.09% | 2.23% | -13.19% |
| EBIT | 118.23% | 77.40% | 26.66% | 9.42% | -3.08% |
| EBITDA | 120.40% | 79.03% | 27.90% | 10.78% | -1.53% |
| EPS Basic | 119.78% | 79.42% | 26.07% | 5.70% | -9.64% |
| Normalized Basic EPS | 118.68% | 78.70% | 30.97% | 13.17% | 0.55% |
| EPS Diluted | 118.68% | 78.60% | 25.12% | 5.26% | -9.64% |
| Normalized Diluted EPS | 118.68% | 78.70% | 30.97% | 13.17% | 0.55% |
| Average Basic Shares Outstanding | 2.44% | 3.44% | 4.46% | 3.52% | 2.59% |
| Average Diluted Shares Outstanding | 5.38% | 6.29% | 7.22% | 4.91% | 2.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |